Since our study also showed an association of POLQ overexpression in lung cancer cells with mutation induction, PLK4 overexpression, which contributes to centrosome amplification, and resistance to DSBs, it is speculated that POLQ overexpression contributes to increasing the malignant potential of LAC. Here, PLK4 is linked to lung cancer.